[{"address1": "126 East Lincoln Avenue", "city": "Rahway", "state": "NJ", "zip": "07065", "country": "United States", "phone": "908 740 4000", "website": "https://www.merck.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert M. Davis J.D.", "age": 58, "title": "Chairman, President & CEO", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 4946636, "exercisedValue": 12137946, "unexercisedValue": 8920883}, {"maxAge": 1, "name": "Ms. Caroline A. Litchfield", "age": 55, "title": "Executive VP & CFO", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 2647054, "exercisedValue": 2581579, "unexercisedValue": 7022207}, {"maxAge": 1, "name": "Ms. Betty D. Larson", "age": 49, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 2294965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard R. DeLuca Jr.", "age": 62, "title": "Executive VP & President of Merck Animal Health", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 2169938, "exercisedValue": 0, "unexercisedValue": 5823540}, {"maxAge": 1, "name": "Dr. Dean Y. Li M.D., Ph.D.", "age": 61, "title": "Executive VP & President of Merck Research Laboratories", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 3281100, "exercisedValue": 932530, "unexercisedValue": 4699987}, {"maxAge": 1, "name": "Mr. Dalton E. Smart III", "age": 58, "title": "Senior VP of Finance, Principal Accounting Officer & Global Controller", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Michael Williams", "age": 55, "title": "Executive VP and Chief Information & Digital Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Dannenbaum", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Zachary J.D.", "age": 46, "title": "Executive VP & General Counsel", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 2732334, "exercisedValue": 3461623, "unexercisedValue": 4142191}, {"maxAge": 1, "name": "Mr. Sanat  Chattopadhyay", "age": 65, "title": "Executive VP & President of Merck Manufacturing Division", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 2488990, "exercisedValue": 12488854, "unexercisedValue": 7539200}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.merck.com/investors/home.html", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 119.24, "open": 121.5, "dayLow": 121.03, "dayHigh": 123.32, "regularMarketPreviousClose": 119.24, "regularMarketOpen": 121.5, "regularMarketDayLow": 121.03, "regularMarketDayHigh": 123.32, "dividendRate": 3.4, "dividendYield": 2.8, "exDividendDate": 1773619200, "payoutRatio": 0.45049998, "fiveYearAvgDividendYield": 3.05, "beta": 0.296, "trailingPE": 16.677198, "forwardPE": 12.414758, "volume": 10099602, "regularMarketVolume": 10099602, "averageVolume": 14572119, "averageVolume10days": 16528990, "averageDailyVolume10Day": 16528990, "bid": 121.1, "ask": 121.42, "bidSize": 600, "askSize": 800, "marketCap": 303255879680, "fiftyTwoWeekLow": 73.31, "fiftyTwoWeekHigh": 123.33, "allTimeHigh": 134.63, "allTimeLow": 0.265055, "priceToSalesTrailing12Months": 4.6646857, "fiftyDayAverage": 107.9984, "twoHundredDayAverage": 89.76425, "trailingAnnualDividendRate": 3.24, "trailingAnnualDividendYield": 0.02717209, "currency": "USD", "tradeable": false, "enterpriseValue": 324559372288, "profitMargins": 0.28078, "floatShares": 2478026480, "sharesOutstanding": 2482022536, "sharesShort": 28729402, "sharesShortPriorMonth": 32573724, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0116, "heldPercentInsiders": 0.00062, "heldPercentInstitutions": 0.79802, "shortRatio": 2.37, "shortPercentOfFloat": 0.0128999995, "impliedSharesOutstanding": 2497783212, "bookValue": 20.845, "priceToBook": 5.8244185, "lastFiscalYearEnd": 1767139200, "nextFiscalYearEnd": 1798675200, "mostRecentQuarter": 1767139200, "earningsQuarterlyGrowth": -0.208, "netIncomeToCommon": 18254000128, "trailingEps": 7.28, "forwardEps": 9.77949, "lastSplitFactor": "1048:1000", "lastSplitDate": 1622678400, "enterpriseToRevenue": 4.992, "enterpriseToEbitda": 11.27, "52WeekChange": 0.45767796, "SandP52WeekChange": 0.11527538, "lastDividendValue": 0.85, "lastDividendDate": 1765756800, "quoteType": "EQUITY", "currentPrice": 121.41, "targetHighPrice": 150.0, "targetLowPrice": 100.0, "targetMeanPrice": 124.88462, "targetMedianPrice": 126.5, "recommendationMean": 1.85714, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 18214000640, "totalCashPerShare": 7.338, "ebitda": 28797331456, "totalDebt": 41373999104, "totalRevenue": 65010999296, "debtToEquity": 79.708, "revenuePerShare": 25.932, "returnOnEquity": 0.37166, "grossProfits": 50112999424, "earningsGrowth": -0.193, "revenueGrowth": 0.05, "grossMargins": 0.77084, "ebitdaMargins": 0.44296002, "operatingMargins": 0.32561, "financialCurrency": "USD", "symbol": "MRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 1.81986, "regularMarketPrice": 121.41, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": -252322200000, "postMarketChangePercent": -0.06309756, "postMarketPrice": 121.3334, "postMarketChange": -0.07660675, "regularMarketChange": 2.17001, "regularMarketDayRange": "121.03 - 123.32", "exchange": "NYQ", "messageBoardId": "finmb_288502", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Merck & Company, Inc.", "corporateActions": [], "postMarketTime": 1771030658, "regularMarketTime": 1771016402, "priceEpsCurrentYear": 23.599457, "fiftyDayAverageChange": 13.411606, "fiftyDayAverageChangePercent": 0.12418338, "twoHundredDayAverageChange": 31.645752, "twoHundredDayAverageChangePercent": 0.35254294, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "longName": "Merck & Co., Inc.", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 14572119, "fiftyTwoWeekLowChange": 48.100006, "fiftyTwoWeekLowChangePercent": 0.656118, "fiftyTwoWeekRange": "73.31 - 123.33", "fiftyTwoWeekHighChange": -1.9199982, "fiftyTwoWeekHighChangePercent": -0.015567973, "fiftyTwoWeekChangePercent": 45.767796, "dividendDate": 1775520000, "earningsTimestamp": 1777555800, "earningsTimestampStart": 1777555800, "earningsTimestampEnd": 1777555800, "earningsCallTimestampStart": 1777554000, "earningsCallTimestampEnd": 1777554000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 7.28, "epsForward": 9.77949, "epsCurrentYear": 5.14461, "displayName": "Merck &", "trailingPegRatio": 2.8459, "__fetch_time": "2026-02-14"}]